Neurobiology and neuropharmacology of monoaminergic systems

Philippe Deurwaerdère; Rona R. Ramsay; Giuseppe Di Giovanni

doi:10.1016/j.pneurobio.2017.02.001

Neurobiology and neuropharmacology of monoaminergic systems

Philippe Deurwaerdère, Rona R. Ramsay, Giuseppe Di Giovanni

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Article number	PRONEU 1480
Pages (from-to)	1-3
Number of pages	3
Journal	Progress in Neurobiology
Volume	151
Early online date	2 Mar 2017
DOIs	https://doi.org/10.1016/j.pneurobio.2017.02.001
Publication status	Published - Apr 2017

Access to Document

10.1016/j.pneurobio.2017.02.001

EditorialPr0gNeurobiol_accepted ms
© 2017, Elsevier. This work has been made available online in accordance with the publisher’s policies. This is the author created, accepted version manuscript following peer review and may differ slightly from the final published version. The final published version of this work is available at www.sciencedirect.com / https://doi.org/10.1016/j.pneurobio.2017.02.001
Accepted author manuscript, 213 KB

Cite this

@article{98a7c6fa468b459fbdb80e6705a597d2,

title = "Neurobiology and neuropharmacology of monoaminergic systems",

author = "Philippe Deurwaerd{\`e}re and Ramsay, {Rona R.} and {Di Giovanni}, Giuseppe",

note = "This Special Issue, and the collaboration among the researchers that contributed to it, was initiated by EU COST Action CM1103 “Structure-based drug design for diagnosis and treatment of neurological diseases: dissecting and modulating complex function in the monoaminergic systems of the brain”.",

year = "2017",

month = apr,

doi = "10.1016/j.pneurobio.2017.02.001",

language = "English",

volume = "151",

pages = "1--3",

journal = "Progress in Neurobiology",

issn = "0301-0082",

publisher = "Elsevier",

}

TY - JOUR

T1 - Neurobiology and neuropharmacology of monoaminergic systems

AU - Deurwaerdère, Philippe

AU - Ramsay, Rona R.

AU - Di Giovanni, Giuseppe

N1 - This Special Issue, and the collaboration among the researchers that contributed to it, was initiated by EU COST Action CM1103 “Structure-based drug design for diagnosis and treatment of neurological diseases: dissecting and modulating complex function in the monoaminergic systems of the brain”.

PY - 2017/4

Y1 - 2017/4

U2 - 10.1016/j.pneurobio.2017.02.001

DO - 10.1016/j.pneurobio.2017.02.001

M3 - Editorial

SN - 0301-0082

VL - 151

SP - 1

EP - 3

JO - Progress in Neurobiology

JF - Progress in Neurobiology

M1 - PRONEU 1480

ER -